Article Text

PDF
Original article
Timing of troponin I measurement in pulmonary embolism
  1. Emile Ferrari,
  2. Pamela Moceri,
  3. Christophe Crouzet,
  4. Denis Doyen,
  5. Pierre Cerboni
  1. Department of Cardiology, University Hospital of Nice, Nice, France
  1. Correspondence to Dr Pamela Moceri, Department of Cardiology, University Hospital of Nice, 30 Avenue de la Voie Romaine, Nice 06002, France; moceri.p{at}chu-nice.fr

Abstract

Background Troponin I (TnI) is an important prognostic marker and risk-stratification tool in patients with pulmonary embolism (PE). However, the best timing for this biomarker measurement is still unclear.

Objective To analyse the kinetics of TnI in patients hospitalised for PE in order to better ascertain the evolution of the biomarker in this disease. In particular, we attempted to determine which measurement is the most appropriate to assess the PE risk according to this biomarker's status.

Design, setting, patients and main outcome measures This was a prospective, single center, cohort study. TnI (Beckman Access method) was measured on admission, then every 8 h for 72 h in 200 stable patients hospitalised for PE in our cardiology department. Patients were classified into two groups: TnI−(negative) or TnI +.

Results Mean TnI peak occurred at H8: 0.67±0.55 ng/ml. TnI values then decreased quickly, but remained positive (>0.06 ng/ml) beyond the 72-h surveillance period. The TnI biological profile varied widely after admission. Of the patients TnI− on the first assessment, 15% were positive at the second measurement. Among patients hospitalised less than 24 h after the onset of symptoms, 30% were misclassified on admission. In all cases, the second assessment, eight hours after admission, gave the biomarker's true status.

Conclusion Our study clarifies the kinetics of TnI in PE and highlights the situations in which an early TnI can be false negative. Many misclassifications could be avoided by taking into account the value of this biomarker obtained at H8.

  • Biomarkers
  • pulmonary embolism
  • troponin I

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Ethics approval Nice University Hospital ethics committee.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.